Emerging studies suggest this peptide, a dual activator targeting both GLP-1 and another hormone, may offer a significant step forward for weight management . Preliminary patient tests have indicated substantial losses in abdominal mass , conceivably exceeding other weight-loss therapies . Despite this, further assessment is needed to thoroughly de